Surgical treatment of type 2 diabetes mellitus. Analysis of long-term remission
- 作者: Neimark A.E.1, Danilov I.N.1, Shulyakovskaya A.S.1, Lapshina S.E.1, Kornyushin O.V.1, Salov M.A.1
-
隶属关系:
- Almazov National Medical Research Centre
- 期: 卷 33, 编号 12 (2022)
- 页面: 70-74
- 栏目: From Practice
- URL: https://journals.eco-vector.com/0236-3054/article/view/321335
- DOI: https://doi.org/10.29296/25877305-2022-12-13
- ID: 321335
如何引用文章
详细
Type 2 diabetes mellitus (DM2) and obesity are diseases that have a negative impact on public health. They are associated with significant morbidity and mortality, and despite lifestyle changes and the possibility of conservative therapy, it is still difficult to achieve glycemic control. Currently, there are practically no studies in the Russian-language literature on long-term remission after surgical treatment of DM2. This review aimed to identify and summarize evidence of the long-term effect of bariatric surgery on remission of DM2. There is no relationship between the type of bariatric intervention and the fact of remission. Each of the operated patients showed a decrease in overweight and, as a result, an improvement in the course of DM2.
Bariatric surgery is now established as an effective and safe therapy for morbid obesity and its associated morbidities. Patients who have not achieved remission, despite this, have an improvement in the quality of life. Bariatric surgery also corrected or alleviated a number of other comorbidities of obesity.
全文:
作者简介
A. Neimark
Almazov National Medical Research Centre
编辑信件的主要联系方式.
Email: sas_spb@mail.ru
ORCID iD: 0000-0003-4925-0126
Candidate of Medical Sciences
俄罗斯联邦, Saint PetersburgI. Danilov
Almazov National Medical Research Centre
Email: sas_spb@mail.ru
ORCID iD: 0000-0001-9540-7812
Candidate of Medical Sciences
俄罗斯联邦, Saint PetersburgA. Shulyakovskaya
Almazov National Medical Research Centre
Email: sas_spb@mail.ru
ORCID iD: 0000-0002-3663-1934
俄罗斯联邦, Saint Petersburg
S. Lapshina
Almazov National Medical Research Centre
Email: sas_spb@mail.ru
ORCID iD: 0000-0001-6754-1942
俄罗斯联邦, Saint Petersburg
O. Kornyushin
Almazov National Medical Research Centre
Email: sas_spb@mail.ru
Candidate of Medical Sciences
俄罗斯联邦, Saint PetersburgM. Salov
Almazov National Medical Research Centre
Email: sas_spb@mail.ru
ORCID iD: 0000-0002-9530-3447
俄罗斯联邦, Saint Petersburg
参考
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й вып. (дополненный). М., 2021 [Standards of specialized diabetes care. Ed. by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th Ed. М., 2021 (in Russ.)]. doi: 10.14341/DM12802
- Adams T., Davidson L., Litwin S. et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012; 308 (11): 1122–31. doi: 10.1001/2012.jama.11164
- Affinati A., Esfandiari N., Oral E. et al. Bariatric Surgery in the Treatment of Type 2 Diabetes. Curr Diab Rep. 2019; 19 (12): 156. doi: 10.1007/s11892-019-1269-4
- Arterburn D., Bogart A., Sherwood N. et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013; 23 (1): 93–102. doi: 10.1007/s11695-012-0802-1
- Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122 (3): 248–56. doi: 10.1016/j.amjmed.2008.09.041
- Cantay H., Binnetoglu K., Erdogdu U. et al. Comparison of short- and long-term outcomes of bariatric surgery methods: A retrospective study. Medicine (Baltimore). 2022; 101 (38): e30679. doi: 10.1097/MD.0000000000030679
- Chen Y., Corsino L., Shantavasinkul P. et al. Gastric bypass surgery leads to long-term remission or improvement of type 2 diabetes and significant decrease of microvascular and macrovascular complications. Ann Surg. 2016; 263 (6): 1138–42. doi: 10.1097/SLA.0000000000001509
- Chikunguwo S., Wolfe L., Dodson P. et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010; 6 (3): 254–9. doi: 10.1016/j.soard.2009.11.003
- Coleman K., Haneuse S., Johnson E. et al. Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care. 2016; 39 (8): 1400–7. doi: 10.2337/dc16-0194
- Courcoulas A., Gallagher J., Neiberg R. et al. Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial. J Clin Endocrinol Metab. 2020; 105 (3): 866–76. doi: 10.1210/clinem/dgaa006
- DiGiorgi M., Rosen D., Choi J. et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010; 6 (3): 249–53. doi: 10.1016/j.soard.2009.09.019
- Guenzi M., Arman G., Rau C. et al. Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. Surg Endosc. 2015; 29 (9): 2669–74. doi: 10.1007/s00464-014-3987-7
- Gulliford M., Booth H., Reddy M. et al. Effect of contemporary bariatric surgical procedures on type 2 diabetes remission. A population-based matched cohort study. Obes Surg. 2016; 26 (10): 2308–15. doi: 10.1007/s11695-016-2103-6
- Fink J., Seifert G., Blüher M. et al. Obesity Surgery. Dtsch Arztebl Int. 2022; 119 (5): 70–80. doi: 10.3238/arztebl.m2021.0359
- Hsu C., Almulaifi A., Chen J. et al. Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg. 2015; 150 (12): 1117–24. doi: 10.1001/jamasurg.2015.2602
- Iaconelli A., Panunzi S., De Gaetano A. et al. Effects of bilio- pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011; 34 (3): 561–7. doi: 10.2337/dc10-1761
- Kelsey M., Nelson A., Green J. et al. Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison. J Am Coll Cardiol. 2022; 79 (18): 1849–57. doi: 10.1016/j.jacc.2022.02.046
- Khorgami Z., Shoar S., Saber A. et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019; 29 (3): 964–74. doi: 10.1007/s11695-018-3552-x
- Lee W.-J., Chong K., Lin Y. et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014; 24 (9): 1552–62. doi: 10.1007/s11695-014-1344-5
- MacDonald K.G., Long S., Swanson M. et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997; 1 (3): 213–20. doi: 10.1016/s1091-255x(97)80112-6
- Madsen L., Baggesen L., Richelsen B. et al. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population – based matched cohort study. Diabetologia. 2019; 62 (4): 611–20. doi: 10.1007/s00125-019-4816-2
- Mingrone G., Panunzi S., De Gaetano A. et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial. Lancet. 2015; 386 (9997): 964–73. doi: 10.1016/S0140-6736(15)00075-6
- Musella M., Apers J., Rheinwalt K. et al. Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey. Obes Surg. 2016; 26 (5): 933–40. doi: 10.1007/s11695-015-1865-6
- Panunzi S., Carlsson L., De Gaetano A. et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care. 2016; 39 (1): 166–74. doi: 10.2337/dc15-0575
- Pories W., Swanson M., MacDonald K.G. et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222 (3): 339–50. doi: 10.1097/00000658-199509000-00011
- Riddle M., Cefalu W., Evans P. et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care. 2021; 44 (10): 2438–44. doi: 10.2337/dci21-0034
- Schauer P., Bhatt D., Kirwan J. et al. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. NEJM. 2017; 376 (7): 641–51. doi: 10.1056/NEJMoa1600869
- Sheng B., Truong K., Spitler H. et al. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg. 2017; 27 (10): 2724–32. doi: 10.1007/s11695-017-2866-4
- Sjostrom L., Peltonen M., Jacobson P. et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311 (22): 2297–304. doi: 10.1001/jama.2014.5988
- The American Diabetes Association. Standards of medical care in diabetes – 2013. Diabetes Care. 2013; 36 (Suppl 1): S11–66. doi: 10.2337/dc13-S011
- Yan Y., Sha Y., Yao G. et al. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2016; 95 (17): e3462. doi: 10.1097/MD.0000000000003462
- Zakaria A., Rossetti L., Cristina M. et al. Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis. 2016; 12 (3): 587–95. doi: 10.1016/j.soard.2015.10.062